Top Story

FDA to review pediatric hexavalent vaccine

October 21, 2014

The FDA has accepted for review a Biologics License Application filed by Merck and Sanofi Pasteur for a pediatric hexavalent combination vaccine containing DTaP, inactivated poliovirus, Haemophilus influenzae type B and hepatitis B vaccines, according to a company press release.

The application acceptance is based on phase 3 study data, presented at IDWeek 2014 in Philadelphia, which indicated vaccine safety and immunogenicity among infants.

figure

NIH awards seven research grants for vaccine adjuvants

October 18, 2014
The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded seven research grants to separate institutions to explore and develop new…

$5.8 million contract awarded for development of third Ebola vaccine

October 17, 2014
The US Department of Health and Human Services announced a $5.8 million contract toward the development of a third Ebola vaccine, according to a press release.The…
In the Journals

Vaccination coverage rates high among US kindergarteners

October 16, 2014
Routine vaccination coverage among children in kindergarten was at or near the 95% national Healthy People 2020 target for DTaP, measles-mumps-rubella and…
CME CME

Prevention and Control of Influenza and Dengue Through Vaccine Development

Pediatric Annals, August 2013, Volume 42 Issue 8
CME Educational Objectives1.Review the impact of influenza infection in the pediatric…
More »
CME
figure

Immunization An Update

Keck School of Medicine of USC and Pediatric Annals

In the current environment of increasing vaccine refusal, the pediatrician has a powerful role to play as a trusted…
More »

Filter By:

More Headlines »